Castrate Resistant Prostate Cancer

Metastatic Castration Resistant Prostate Cancer (mCRPC) – Inroads in Improved Outcomes

Grand Rounds in Urology

Updates in the treatment of castration-resistant prostate cancer

Castrate resistant prostate cancer

The Prostate Coach

Understanding Metastatic Castration-Resistant Prostate Cancer

Grand Rounds in Urology

Treatment Landscape of Castrate-Resistant Prostate Cancer

Treatment options for patients with metastatic castration-resistant prostate cancer

Treating Non-Metastatic Castrate Resistant Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

Prostate Cancer Research Institute

What is Castration-Resistant Prostate Cancer?

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Treatment sequencing for metastatic castration-resistant prostate cancer

Metastatic Castrate-Resistant Prostate Cancer: Options and Possible Sequences

Grand Rounds in Urology

Exploring The Evolution In Metastatic Hormone Sensitive & Castration Resistant Prostate Cancer

Testing the Validity of a Prognostic Model for Castration-Resistant Prostate Cancer

Castration Resistant #ProstateCancer | #MarkScholzMD #PCRI

Prostate Cancer Research Institute

Abiraterone vs docetaxel for metastatic castrate resistant prostate cancer

Advances in non-metastatic castration-resistant prostate cancer

Evaluating the role of SBRT in metastatic castrate-resistant prostate cancer

Castration Resistant Prostate Cancer - Developments and Challenges from 2020

Grand Rounds in Urology

AUA Castration-Resistant Prostate Cancer Guidelines

A Case of Metastatic Castration-Resistant Prostate Cancer

Targeted Oncology